Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 75

Different spinal morphine doses for pain relief after hip replacement

Official title: Comparison of Safety Profile and Efficacy of Different Doses of Intrathecal Morphine in Total Hip Replacement.

Run by Medical University of Silesia · NCT06878014 · Data updated 2026-11-12

This trial tests whether different doses of morphine given with spinal anesthesia reduce pain and balance safety after total hip replacement in adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment120 (estimated)
SponsorMedical University of Silesia
Academic / other
Locations3 sites (Sosnowiec, Silesian Voivodeship and 2 other locations)
StatusRecruiting
StartedMarch 4, 2025
Main results expectedJune 28, 2026
Study endsJune 28, 2026
Registry record updatedFebruary 12, 2026
Trial IDNCT06878014 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for elective total hip replacement who are ASA physical status I–III, have BMI 19–30, can operate a PCA pump, and can give informed consent are ideal candidates.

Probably not a fit

Patients with BMI over 30, chronic preoperative pain or regular opioid use, contraindications to spinal anesthesia, or inability to use a PCA pump may not receive benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults having elective total hip replacement receive spinal bupivacaine combined with varying doses of intrathecal morphine and standardized postoperative multimodal analgesia, including acetaminophen, an NSAID or metamizole, and PCA IV oxycodone as needed. The study tracks pain scores, opioid consumption, and adverse events—with particular attention to respiratory depression—primarily during the first 24 hours after surgery. Eligible participants are ASA I–III with BMI 19–30, able to use a PCA pump, and without chronic preoperative opioid use or contraindications to spinal anesthesia. The goal is to find a morphine dose that prolongs pain relief while minimizing serious side effects.

Why it matters

Potential benefit: If successful, the trial could identify a morphine dose that provides longer post-operative pain relief with fewer serious side effects like respiratory depression.

How similar studies have gone: Prior research shows intrathecal morphine prolongs postoperative analgesia but carries dose-dependent risk of respiratory depression, so dose-finding work is common and needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent to participate in trial
* Qualification for total hip replacement surgery
* ASA physical status I-III
* BMI 19-30
* Lack of contraindications for drugs and interventions used in trial

Exclusion Criteria:

* Incapability to provide informed consent
* Contraindications for spinal anesthesia
* Preoperative chronic pain
* Chronic use of analgesics
* Obesity (BMI\>30)
* Allergies and other contraindications for drugs used in trial
* Mental or physical incapability to operate PCA syringe pump

Where it's running

  • Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary
    Sosnowiec, Silesian Voivodeship, Poland
    Recruiting
  • Zespół Opieki Zdrowotnej w Końskich
    Gmina Końskie, Świętokrzyskie Voivodeship, Poland
    Recruiting
  • Uniwersytecki Szpital Kliniczny nr 1 im. prof. Tadeusza Sokołowskiego PUM w Szczecinie
    Szczecin, West Pomeranian Voivodeship, Poland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.